Neonatal SEPSIS Clinical Trial
Official title:
Severity Index of Neonatal Septicemia of Cases Admitted at Neonatal Intensive Care Units at CHILDREN'S HOSPITAL, CAIRO UNIVERSITY and at ELGALAA Children's MILITARY HOSPITAL Using Score for Neonatal Acute Physiology (SNAP) II
To determine the effect of Score for Neonatal Acute Physiology II as a Predictor of Mortality and Organ Dysfunction in Neonates with Septicemia in the Neonatal Intensive Care Units at CHILDREN'S HOSPITAL, CAIRO UNIVERSITY and at ELGALAA Children's MILITARY HOSPITAL.
This study will be conducted at the Neonatal intensive care Units at CHILDREN'S HOSPITAL,
CAIRO UNIVERSITY and at ELGALAA Children's MILITARY HOSPITAL.
Population of study & disease condition:
Neonates with septicemia admitted to NICUs in CHILDREN'S HOSPITAL, CAIRO UNIVERSITY and in
ELGALAA Children's MILITARY HOSPITAL.
Inclusion criteria:
1. Type of patient: Neonates with septicemia.
2. Age of patient: From 0-28 Days.
3. Sex: males and females.
Exclusion criteria:
1. Neonates with proved inborn error of metabolism.
2. Neonates with multiple congenital anomalies.
3. Neonates with severe birth asphyxia (APGAR score <4 at 5 minutes).
Methodology in details:
We will have 2 groups, each of them 50 neonates with septicemia. One group of premature
neonates (32-36 weeks), the other group of full term neonates (>37 weeks).
All included Patients will be subjected to the following:
1. Full history with emphasis of relevant data as follows:
Date of birth, gestational age (AGA or SGA), gender, day of sepsis onset.
2. Clinical assessment:
Full systems examination.
3. Diagnosis of sepsis:
- By abnormal Total leucocytic count or I/T ratio or CRP with clinical Suggestion
(poor feeding, hepatomegaly, apnea, tachypnea, lethargy, …).
- Confirm diagnosis by blood culture.
Sepsis will be considered severe if the neonate has sepsis plus one of the following: 1)
cardiovascular organ dysfunction (hypotension or need for vasoactive drug) 2) 2 of the
following (metabolic acidosis, increase lactic acid, oliguria, Prolonged capillary
refill time) 3) Organ dysfunction (respiratory, renal, neurologic, hematologic).
4. SNAP II score:
For all neonates included in the study and its data collection within 24 hours from
onset of sepsis, in the form of:
- Lowest mean blood pressure.
- Worst ratio of pao2/fio2
- Lowest temperature.
- Lowest serum PH.
- Occurrence of multiple seizures.
- Urine output<1 ml/kg/hour.
5. Follow up:
Follow up all neonates included in the study for 14 days: for morbidity and mortality.
6. Diagnosis of organ dysfunction:
Respiratory: by CXR and clinical examination. CVS: by blood pressure, capillary refill time,
shock and need for inotropes. Renal: by urine output, kidney function tests. Hematology: by
picture of DIC or pancytopenia. Neurology: by seizures, dilated fixed pupil.
Possible Risk:
Primary outcomes:
Using Score for Neonatal Acute Physiology II as a Predictor of Mortality and Organ
Dysfunction in Neonates with Septicemia.
Secondary outcomes:
Early anticipation of clinical manifestations of sepsis which will correlate most with poor
outcome.
Sample size:
100 Neonates with septicemia admitted to NICUs in CHILDREN'S HOSPITAL, CAIRO UNIVERSITY and
in ELGALAA Children's MILITARY HOSPITAL.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT05692128 -
Frequency and Severity of Thrombocytopenia in Neonatal Sepsis
|
||
Completed |
NCT00942084 -
A Study to Describe the Pharmacokinetics of Acyclovir in Premature Infants (PTN_Acyclo)
|
Phase 1 | |
Completed |
NCT06002295 -
A Comparative Analysis of 4% Chlorhexidine Versus Methylated Spirit as Prophylaxis of Omphalitis and Sepsis in Newborns
|
Phase 2 | |
Not yet recruiting |
NCT05114057 -
Use of NGAL for Fluid Dosing and CRRT Initiation in Pediatric and Neonatal AKI
|
N/A | |
Recruiting |
NCT04528251 -
Comparison of the Effectiveness of Two Different Antibiotic Regimens of the Treatment of Pregnant Women With Preterm Rupture of Membranes
|
||
Active, not recruiting |
NCT03871491 -
Azithromycin-Prevention in Labor Use Study (A-PLUS)
|
Phase 3 | |
Completed |
NCT02386592 -
Prevention of Nosocomial Bacteremia Among Zambian Neonates
|
N/A | |
Not yet recruiting |
NCT06113653 -
Outcomes and Predictors of Mortality Among Preterm Infants With Neonatal Sepsis
|
||
Completed |
NCT03199547 -
Pre-delivery Administration of Azithromycin to Prevent Neonatal Sepsis & Death
|
Phase 3 | |
Completed |
NCT02147327 -
Effects of Cord Blood 25-hydroxy-vitamin D Level on Early Neonatal Morbidities
|
N/A | |
Completed |
NCT01005589 -
CD64 Measurement in Neonatal Infection and Necrotising Enterocolitis
|
N/A | |
Completed |
NCT00866567 -
Defects in Opsonophagocytosis in Premature Infants
|
N/A | |
Completed |
NCT02281890 -
Neurodevelopmental Outcomes After Suspected or Proven Sepsis: Secondary Analysis of INIS Trial Database
|
N/A | |
Suspended |
NCT05156333 -
Probiotics and GBS Colonization in Pregnancy
|
N/A | |
Recruiting |
NCT05127070 -
Evaluating the NeoTree in Malawi and Zimbabwe
|
||
Completed |
NCT03755635 -
Neonatal Sepsis at Neonatal Intensive Care Units in Ghana
|
N/A | |
Completed |
NCT03247920 -
Reduction of Intravenous Antibiotics In Neonates
|
Phase 4 | |
Completed |
NCT03295162 -
Effects of Melatonin as a Novel Antioxidant and Free Radicals Scavenger in Neonatal Sepsis
|
Phase 1/Phase 2 | |
Completed |
NCT02954926 -
Intravenous Immunoglobulin in Prevention of Preterm Neonatal Sepsis
|
Phase 3 | |
Withdrawn |
NCT01723501 -
Chlorhexidine Skin Application for Prevention of Infection in Infants Weighing <1500 g at Birth
|
Phase 2/Phase 3 |